References
- Guslandi M. Comparison of sucralfate and ranitidine in the treatment of chronic nonerosive gastritis. A randomized, multi-center trial. Am J Med 1989; 6A: 45–8, 86 Suppl
- Giacosa A, Turello V, Icardi A. Secretion gastrique acide, gastrinemie et masse cellulaire parietale dans les gastrites chroniques. Gastroenterol Clin Biol 1978; 2: 133–5
- Guslandi M, Ballarin E. Assessment of the mucus-bicarbonate barrier in the stomach of patients with chronic gastric disorders. Clin Chim Acta 1984; 144: 133–6
- McNulty C AM. Pathogenicity of Campylobacter pylori–a causative factor in gastritis?. Scand J Gastroenterol 1989; 160: 3–6, 24 Suppl
- Barbara L, Biasco G, Capurso L, et al. Campylobacter-like organisms and gastritis in patients with non ulcer dyspepsia: a histological study. Ital J Gastroenterol 1989; 21: 2–5
- Loffeld R JLF, Potters H VJP, Stobberingh E, Flendring J A, Van Spreeuwel J P, Arends J W. Campylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind placebo controlled trial with colloidal bismuth subcitrate. Gut 1989; 30: 1206–12
- Dal Monte P R, D'Imperio N, Accardo P, Daniotti S. Piren-zepine in non-ulcer dyspepsia. A double-blind, placebo-controlled trial. Scand J Gastroenterol 1982; 72: 247–50, 17 Suppl
- Rokkas T, Pursey C, Uzoechina E, et al. Non-ulcer dyspepsia and short-term De Nol therapy: a placebo controlled trial with particular reference to the role of Campylobacter pylori. Gut 1988; 29: 1386–91
- Hojgaard L, Matzen P, Christoffersen P. Gastritis–a clinical entity?. Scand J Gastroenterol 1987; 128: 90–3, 22 Suppl
- Elta G H, Appelman H D, Behler E M, Wilson J AP, Nostrant T J. A study of the correlation between endoscopic and histological diagnosis in gastroduodenitis. Am J Gastroenterol 1987; 82: 749–53
- Lam S K. Implications of sucralfate-induced ulcer healing and relapse. Am J Med 1989; 6A: 122–6, 85 Suppl
- Lambert J R. Effect of anti-ulcer drugs on Helicobacter pylori. Drug Invest 1990; 1: 52–5, 2 Suppl